These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 21051706)

  • 21. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials.
    Varma R; Bressler NM; Suñer I; Lee P; Dolan CM; Ward J; Colman S; Rubio RG;
    Ophthalmology; 2012 Oct; 119(10):2108-18. PubMed ID: 22817833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Retinal Microcirculation After Intravitreal Ranibizumab Injection in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Fukami M; Iwase T; Yamamoto K; Kaneko H; Yasuda S; Terasaki H
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1246-1255. PubMed ID: 28241312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trial.
    Brown DM; Wykoff CC; Wong TP; Mariani AF; Croft DE; Schuetzle KL;
    Retina; 2014 Sep; 34(9):1728-35. PubMed ID: 24914476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Spaide RF; Chang LK; Klancnik JM; Yannuzzi LA; Sorenson J; Slakter JS; Freund KB; Klein R
    Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.
    Brown DM; Campochiaro PA; Bhisitkul RB; Ho AC; Gray S; Saroj N; Adamis AP; Rubio RG; Murahashi WY
    Ophthalmology; 2011 Aug; 118(8):1594-602. PubMed ID: 21684606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranibizumab and retinal vein occlusion. Too many outstanding questions.
    Prescrire Int; 2012 Sep; 21(130):207. PubMed ID: 23016250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-VEGF treatment in branch retinal vein occlusion: a real-world experience over 4 years.
    Rezar S; Eibenberger K; Bühl W; Georgopoulos M; Schmidt-Erfurth U; Sacu S;
    Acta Ophthalmol; 2015 Dec; 93(8):719-25. PubMed ID: 26109209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
    Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
    BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.
    Boyer D; Heier J; Brown DM; Clark WL; Vitti R; Berliner AJ; Groetzbach G; Zeitz O; Sandbrink R; Zhu X; Beckmann K; Haller JA
    Ophthalmology; 2012 May; 119(5):1024-32. PubMed ID: 22440275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinal blood flow in response to an intravitreal injection of ranibizumab for neovascular age-related macular degeneration.
    Micieli JA; Tsui E; Lam WC; Brent MH; Devenyi RG; Hudson C
    Acta Ophthalmol; 2012 Feb; 90(1):e13-20. PubMed ID: 21801339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion.
    Hasegawa T; Takahashi Y; Maruko I; Kogure A; Iida T
    Br J Ophthalmol; 2019 Oct; 103(10):1367-1372. PubMed ID: 30514711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of retinal sensitivity to ranibizumab treatment of macular edema after acute branch retinal vein occlusion.
    Mylonas G; Sacu S; Dunavoelgyi R; Matt G; Blum R; Buehl W; Pruente C; Schmidt-Erfurth U;
    Retina; 2013 Jun; 33(6):1220-6. PubMed ID: 23584689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.
    Brown DM; Campochiaro PA; Singh RP; Li Z; Gray S; Saroj N; Rundle AC; Rubio RG; Murahashi WY;
    Ophthalmology; 2010 Jun; 117(6):1124-1133.e1. PubMed ID: 20381871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment.
    Kaneda S; Miyazaki D; Sasaki S; Yakura K; Terasaka Y; Miyake K; Ikeda Y; Funakoshi T; Baba T; Yamasaki A; Inoue Y
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2982-8. PubMed ID: 21273540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion.
    Shimura M; Yasuda K
    Br J Ophthalmol; 2015 Feb; 99(2):215-9. PubMed ID: 25185254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM; Chiu YT; Hung PT; Tsai YY
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collateral vessel presence in branch and central retinal vein occlusions and their impact on visual acuity and anatomical gains: a retrospective analysis.
    Singh RP; Lee TJ; Yau L; Rubio RG
    Retina; 2014 Nov; 34(11):2242-9. PubMed ID: 25046394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.